AGO2 promotes tumor progression in KRAS-driven mouse models of non-small cell lung cancer. Tien JC, Chugh S, Goodrum AE, Cheng Y, et al. Proc Natl Acad Sci U S A 2021;118.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tien JC, Chugh S, Goodrum AE, Cheng Y, et al. AGO2 promotes tumor progression in KRAS-driven mouse models of non-small cell lung cancer. Proc Natl Acad Sci U S A 2021;118.
PMID: 33972443